CALM1 and cancer: While this could be related to the alteration of CaM interaction with different binding partners that control different phases of the cell cycle, we cannot exclude that the anti-cancer effects of PTZs and their effect on cell cycle regulation might be mediated by distinct mechanisms that might be, in some cases, CaM-independent.